Description
Frontmatter — Authors — Contents — Introduction — Diagnosis of irritable bowel syndrome — Psychosocial profile of patients with irritable bowel syndrome — Awareness of IBS by patients and physicians — Pharmacological aspects of mebeverine and antispasmodics as related to irritable bowel syndrome — A new mebeverine formulation in clinical practice — Risk-benefit ratio of IBS treatment: data from a high dose mebeverine study
